Agile Therapeutics Stock News

PRINCETON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will p

Twirla® on Track for Commercial Launch in Fourth Quarter 2020 $87.2 Million in Cash and Cash Equivalents as of June 30, 2020 Management to Host Conference Call at 4:30 PM ETPRINCETON, N.J., Aug. 11,

Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...

Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., July 21, 2020 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company,.

C4 Therapeutics Announces the Additions of William McKee as Chief Financial Officer and Jolie M. Siegel as Chief Legal Officer

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma

Agile Therapeutics (AGRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

PRINCETON, N.J., June 16, 2020 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the Company will be added to the Russell 3000® and.

Of all the controversial plays on Wall Street, penny stocks take the cake. The risk-tolerant flock to these names as the potential for share prices to grow from pocket change to more than a few dollar

Q1 2020 Agile Therapeutics Inc Earnings Call

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q1 2020 Earnings Conference Call May 05, 2020, 16:30 ET Company Participants Matthew Riley - IR Alfred Altomari - Chairma

PRINCETON, N.J., May 11, 2020 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer,.